Title / Affiliation
Chief Scientist, CVRM, Astra Zeneca
Title of PDM2021 Presentation
Approach to Precision Medicine for Common Type 2 Diabetes
Chris Rhodes research is on diabetes/obesity/metabolic disease and associated complications. His PhD in Biochemistry is from the University of London, He has had faculty positions at the Harvard Medical School, University of Texas Southwestern Medical School, University of Washington, then at the University of Chicago. He is current Chief Scientist for Cardiovascular, Renal and Metabolic Disease (CVRM) at AstraZeneca, and remains Professor Emeritus at the University of Chicago.